Chesterbrook, PA – May 7, 2025 – Claris AI, a leader in AI-powered enterprise solutions, is excited to announce its acquisition of BioVeras, a company focused on transforming life sciences data collection and transmission. This strategic acquisition enhances Claris AI’s capabilities in the life sciences sector, enabling it to drive innovation in regulatory compliance while upholding the highest standards. The acquisition, backed by investment, will accelerate Claris AI’s expansion in the life sciences field. 

BioVeras, renowned for its FDA-compliant, immutable data solutions, brings its cutting-edge technology into Claris AI’s portfolio. This integration will enable life sciences organizations to streamline regulatory processes, reduce costs, and set new industry standards for trusted data management. 

Paul Elisii, CEO of Claris AI, emphasized the significance of the acquisition: 

“This move deepens our expertise in life sciences, positioning Claris AI as a leader in delivering AI solutions that meet the most rigorous regulatory standards. By acquiring BioVeras, we are poised to enhance speed and efficiency for life sciences companies while reducing compliance costs.” 

Jean Marie Markham, interim CEO of BioVeras, expressed her enthusiasm for the partnership: 

“Joining forces with Claris AI accelerates our mission to revolutionize the way life sciences companies handle critical data. Together, we are setting a new industry standard for handling data efficiently and securely, which will drive better outcomes for our partners.” 

Additionally, the acquisition further supports Claris AI’s work on the health care field and its partnership with Instant Access, a company dedicated to secure patient scheduling. This collaboration leverages Claris AI’s compliance expertise to enhance patient engagement and improve operational efficiency in healthcare networks. Dr. Rob Cloud, co-founder of Instant Access, shared: 

“Integrating Claris AI’s advanced capabilities with our scheduling platform opens up incredible opportunities to transform patient care by making healthcare interactions more accessible and efficient.” 

Todd Kueny, CTO of Claris AI, highlighted the technical synergies: 

“By integrating BioVeras’ technology with Claris AI’s AI-powered compliance solutions, we can offer unmatched capabilities in data integrity and compliance. This partnership enhances our mission of helping businesses innovate responsibly within complex regulatory environments.” 

About Claris AI 

Claris AI delivers enterprise-grade agentic AI systems that accelerate operational efficiency and reduce time to market. By deploying intelligent agents capable of reasoning, decision-making, and executing tasks across business functions, Claris enables organizations to automate complex workflows and drive scalable impact. 

Serving industries such as financial services, life sciences, manufacturing, and consumer products, Claris AI is redefining enterprise AI—moving beyond static chatbots to deploy autonomous systems that operate with context, compliance, and strategic intent. 

For more information, visit http://www.ClarisInsight.ai. 

About BioVeras 

BioVeras transforms the way life sciences companies collect and manage data. As the only FDA-compliant company delivering trusted, immutable data, BioVeras helps reduce the time and cost of regulatory pathways while setting a new industry standard.  For more information, visit https://www.bioveras.com. 

About Instant Access 

Instant Access offers secure AI scheduling solutions powered by Claris AI for healthcare providers, optimizing patient and provider interactions for enhanced operational efficiency. For more information, visit https://www.instantaccesssolutions.com. 

Media Contact: 

[email protected]